ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease

ClinicalTrials.gov ID: NCT01074125

Public ClinicalTrials.gov record NCT01074125. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 11:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD) Following a Two-Week Washout Period

Study identification

NCT ID
NCT01074125
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Keryx Biopharmaceuticals
Industry
Enrollment
154 participants

Conditions and interventions

Interventions

  • ferric citrate Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2010
Primary completion
Oct 31, 2010
Completion
Oct 31, 2010
Last update posted
Dec 3, 2014

2010

United States locations

U.S. sites
15
U.S. states
10
U.S. cities
13
Facility City State ZIP Site status
Western Nephrology Westminster Colorado 80031
Pines Clinical Research, Inc. Pembroke Pines Florida 33028
Kidney Care Associates, LLC Augusta Georgia 30901
Circle Medical Management Chicago Illinois 60607
Western New England Renal & Transplant Associates Springfield Massachusetts 01107
Brookdale Physician's Dialysis Associates Brooklyn New York 11212
DCI Cincinnati Ohio 45206
Cleveland Clinical Foundation Fresenius East (Fairhill) Cleveland Ohio 44104
The Ohio State University Cramblett Medical Clinic Columbus Ohio 43210
Southeast Renal Research Institute Chattanooga Tennessee 37404
Nephrology Associates, PC Nashville Tennessee 37205
Meharry Medical College Clinical Research Center Nashville Tennessee 37208
Vanderbilt University Medical Center Clinical Trials Center Nashville Tennessee 37232-1371
Kidney Associates Houston Texas 77030
Centre Point Dialysis West Allis Wisconsin 53214

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01074125, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 3, 2014 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01074125 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →